Company Filing History:
2 out of 33 
2 out of 15 
2 out of 6 
Years Active: 1984-2013
Title: Emile M Bellott: Innovator in Glucose Biosensing Technology
Introduction
Emile M Bellott is a prominent inventor based in Beverly, MA (US), known for his significant contributions to the field of glucose biosensing technology. With a total of 12 patents to his name, Bellott has made remarkable advancements that have the potential to improve health monitoring for individuals with diabetes.
Latest Patents
One of Bellott's latest innovations is the development of Small Molecule Metabolite Reporters (SMMRs) for use as in vivo glucose biosensors. These SMMRs include boronic acid-containing xanthene, coumarin, carbostyril, and phenalene-based small molecules. They are designed to monitor glucose levels in vivo, particularly on the skin, providing a non-invasive method for glucose monitoring.
Career Highlights
Throughout his career, Emile M Bellott has worked with notable companies such as Masimo Laboratories, Inc. and Interneuron Pharmaceuticals, Inc. His work in these organizations has contributed to the advancement of medical technologies and the development of innovative solutions for health monitoring.
Collaborations
Bellott has collaborated with esteemed professionals in his field, including Yesh P Sachdeva and Carlo Brugnara. These collaborations have fostered a creative environment that has led to groundbreaking innovations in glucose biosensing.
Conclusion
Emile M Bellott's work in developing SMMRs for glucose monitoring exemplifies his dedication to improving health technologies. His contributions continue to influence the field and pave the way for future innovations in biosensing.